Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 4
1998 2
1999 2
2001 1
2005 1
2012 1
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of superficial mycosis treatment using Butenafine and Bifonazole nitrate clinical efficacy.
Abdul Bari MA. Abdul Bari MA. Glob J Health Sci. 2012 Nov 11;5(1):150-4. doi: 10.5539/gjhs.v5n1p150. Glob J Health Sci. 2012. PMID: 23283047 Free PMC article. Clinical Trial.
This study was designed to evaluate the safety and efficacy of Butenafine (BTF) versus Bifonazole (BFZ) in the treatment of superficial mycosis in a randomized, double-blind, parallel-group trial. ...
This study was designed to evaluate the safety and efficacy of Butenafine (BTF) versus Bifonazole (BFZ) in the treatment of superfici …
A comparative study to evaluate efficacy, safety and cost-effectiveness between Whitfield's ointment + oral fluconazole versus topical 1% butenafine in tinea infections of skin.
Thaker SJ, Mehta DS, Shah HA, Dave JN, Kikani KM. Thaker SJ, et al. Indian J Pharmacol. 2013 Nov-Dec;45(6):622-4. doi: 10.4103/0253-7613.121378. Indian J Pharmacol. 2013. PMID: 24347774 Free PMC article. Clinical Trial.
Patients treated with Whitfield's ointment and oral fluconazole reduced mean sign and symptom score from 8.81 0.82 to 0.18 0.59 while butenafine treated patients reduced it from 8.88 0.53 to 0.31 0.67 at the end of the treatment. ...CONCLUSION: Whitfield's ointment with or …
Patients treated with Whitfield's ointment and oral fluconazole reduced mean sign and symptom score from 8.81 0.82 to 0.18 0.59 while but …
Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
Saple DG, Amar AK, Ravichandran G, Korde KM, Desai A. Saple DG, et al. J Indian Med Assoc. 2001 May;99(5):274-5. J Indian Med Assoc. 2001. PMID: 11676116 Clinical Trial.
Besides topical imidazoles, triazoles and allylamines, topical butenafine (a benzylamine derivative) is a novel agent with broad antifungal activity. One hundred and eleven patients with tinea infections were enrolled in this multicentric, randomised, single-blind non-comp …
Besides topical imidazoles, triazoles and allylamines, topical butenafine (a benzylamine derivative) is a novel agent with broad anti …
Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
Tschen E, Elewski B, Gorsulowsky DC, Pariser DM. Tschen E, et al. J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):S9-14. doi: 10.1016/s0190-9622(97)70316-5. J Am Acad Dermatol. 1997. PMID: 9039199 Clinical Trial.
Results reported here are from one of the first major North American butenafine clinical trials. OBJECTIVE: We evaluated butenafine in the treatment of tinea pedis in a controlled, randomized, double-blind trial. ...RESULTS: Significantly more patients using bute …
Results reported here are from one of the first major North American butenafine clinical trials. OBJECTIVE: We evaluated butenafin …
Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial.
Lesher JL Jr, Babel DE, Stewart DM, Jones TM, Kaminester L, Goldman M, Weintraub JS. Lesher JL Jr, et al. J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):S20-4. doi: 10.1016/s0190-9622(97)70318-9. J Am Acad Dermatol. 1997. PMID: 9039201 Clinical Trial.
OBJECTIVE: We compared the safety and efficacy of butenafine hydrochloride and its vehicle when used once daily for 2 weeks to treat tinea cruris. ...Adverse events definitely related to butenafine treatment were limited to one case of burning sensation after applic …
OBJECTIVE: We compared the safety and efficacy of butenafine hydrochloride and its vehicle when used once daily for 2 weeks to treat …
One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
Savin R, De Villez RL, Elewski B, Hong S, Jones T, Lowe N, Lucky A, Reyes B, Stewart D, Willis I. Savin R, et al. J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):S15-9. doi: 10.1016/s0190-9622(97)70317-7. J Am Acad Dermatol. 1997. PMID: 9039200 Clinical Trial.
RESULTS: The rates of all four end points were significantly higher with butenafine than with vehicle 5 weeks after treatment ended. Rates of mycologic cure and effective treatment with butenafine were significantly higher than with vehicle at cessation of treatment …
RESULTS: The rates of all four end points were significantly higher with butenafine than with vehicle 5 weeks after treatment ended. …
The antifungal agent butenafine manifests anti-inflammatory activity in vivo.
Nahm WK, Orengo I, Rosen T. Nahm WK, et al. J Am Acad Dermatol. 1999 Aug;41(2 Pt 1):203-6. doi: 10.1016/s0190-9622(99)70049-6. J Am Acad Dermatol. 1999. PMID: 10426889 Clinical Trial.
Although several studies have demonstrated excellent antimycotic efficacy, none has addressed anti-inflammatory properties associated with butenafine. OBJECTIVE: This study was designed to determine whether butenafine, a benzylamine antifungal, expresses anti-inflam …
Although several studies have demonstrated excellent antimycotic efficacy, none has addressed anti-inflammatory properties associated with …
Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
Singal A, Pandhi D, Agrawal S, Das S. Singal A, et al. J Dermatolog Treat. 2005;16(5-6):331-5. doi: 10.1080/09546630500375783. J Dermatolog Treat. 2005. PMID: 16428155 Clinical Trial.
Localized tinea cruris and tinea corporis can be treated by topical imidazoles (clotrimazole) or newer topical agents like butenafine, a benzylamine derivative with fungicidal activity. The therapeutic efficacy of these two agents was compared in this study. ...Clinical as …
Localized tinea cruris and tinea corporis can be treated by topical imidazoles (clotrimazole) or newer topical agents like butenafine …
Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
Syed TA, Ahmadpour OA, Ahmad SA, Shamsi S. Syed TA, et al. J Dermatol. 1998 Oct;25(10):648-52. doi: 10.1111/j.1346-8138.1998.tb02474.x. J Dermatol. 1998. PMID: 9830263 Clinical Trial.
The purpose of this placebo-controlled, double-blind study was to determine the clinical efficacy, chemical avulsion, and tolerability of 2% butenafine hydrochloride and 20% urea incorporated in a cream to cure toenail onychomycosis in a preselected population. ...Code dis …
The purpose of this placebo-controlled, double-blind study was to determine the clinical efficacy, chemical avulsion, and tolerability of 2% …
Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream.
Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Syed TA, et al. Trop Med Int Health. 1999 Apr;4(4):284-7. doi: 10.1046/j.1365-3156.1999.00396.x. Trop Med Int Health. 1999. PMID: 10357864 Free article. Clinical Trial.
The objective of this randomized, double-blind, placebo-controlled study was to examine the clinical efficacy and tolerability of 2% butenafine hydrochloride and 5% Melaleuca alternifolia oil incorporated in a cream to manage toenail onychomycosis in a cohort. ...
The objective of this randomized, double-blind, placebo-controlled study was to examine the clinical efficacy and tolerability of 2% bute …
12 results